Biography and Research Information
OverviewAI-generated summary
Sofia Syed's research focuses on the health impacts of cancer treatments, specifically investigating changes in the gut microbiome and cognitive function following chemotherapy. Her work examines the relationship between these elements in patients undergoing treatment with doxorubicin, cyclophosphamide, and paclitaxel. Syed collaborates with researchers at the University of Arkansas for Medical Sciences, including Taylor H. McElroy, Beth Cronin, Christa Corley, and Vijayalakshmi Sridharan, with whom she has co-authored publications. Her scholarly activity includes one publication in 2026, indicating recent engagement in the field.
Metrics
- h-index: 3
- Publications: 19
- Citations: 785
Selected Publications
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
Collaboration Network
Top Collaborators
Bailey Cronin
University of Arkansas for Medical Sciences (US)
1 shared publication
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Sangam Kandel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Taylor H. McElroy
University of Arkansas for Medical Sciences (US)
1 shared publication
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Chase Swinton
University of Arkansas for Medical Sciences
1 shared publication
In database
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Christa Corley
University of Arkansas for Medical Sciences
1 shared publication
In database
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Vijayalakshmi Sridharan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Michael S. Robeson
University of Arkansas Medical Center (US)
1 shared publication
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Antiño R. Allen
University of Arkansas Medical Center
1 shared publication
In database
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Similar Researchers
Based on overlapping research topics
Bhavana Sridharan
University of Arkansas for Medical Sciences
Gut microbiota and health
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Bailey Cronin
University of Arkansas for Medical Sciences
Gut microbiota and health
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Taylor McElory
University of Arkansas for Medical Sciences
Gut microbiota and health
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Marjan Boerma
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Qudes Al-Anbaky
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Mitchell Rotenberry
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Disease Mechanisms Research